Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Current ratio
Agilent Technologies, Inc.'s current ratio at the end of the quarter to 31 July 2026 was 2.1×, up 0.1× from fiscal 2025 (2.0×). Over the past ten years it has ranged from 1.5× (fiscal 2019) to 3.8× (fiscal 2016); the current reading is higher than 18% of that period. That is in line with the Diagnostics & Research industry median of 2.0× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Annual
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.0× | (6.31%) |
| FY2024 | 2.1× | (20.00%) |
| FY2023 | 2.6× | 28.63% |
| FY2022 | 2.0× | (8.73%) |
| FY2021 | 2.2× | (4.45%) |
| FY2020 | 2.3× | 51.83% |
| FY2019 | 1.5× | (53.34%) |
| FY2018 | 3.3× | (0.45%) |
| FY2017 | 3.3× | (14.19%) |
| FY2016 | 3.8× | 1.85% |
Quarterly
| Period | Current ratio | Change |
|---|---|---|
| Jul 2026 | 2.1× | (2.33%) |
| Apr 2026 | 2.1× | 1.62% |
| Jan 2026 | 2.1× | 5.54% |
| Oct 2025 | 2.0× | (12.92%) |
| 43 more quarters | Free account |
Against its own ten years
Low 1.5×
High 3.8×
Ten-year median
2.3×
Current reading's percentile
18
Current ratio against peers
| Company | Current ratio |
|---|---|
| GH Guardant Health, Inc. compare | 4.0× |
| NTRA Natera, Inc. compare | 3.0× |
| A Agilent Technologies, Inc. | 2.1× |
| WAT Waters Corporation compare | 1.9× |
| ILMN Illumina, Inc. compare | 1.8× |
| DGX Quest Diagnostics Incorporated compare | 1.6× |
| IDXX IDEXX Laboratories, Inc. compare | 1.2× |
| MTD Mettler-Toledo International, Inc. compare | 1.1× |
| IQV IQVIA Holdings Inc. compare | 0.7× |
| Diagnostics & Research industry median | 2.0× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement